Medical News

RSS

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

By using data representing 80% of the US population, researchers have found that increased vaccination coverage against COVID-19 can be linked to a reduced incidence of cases and deaths.

2 May 2022

Epigenetic abnormalities in hematopoietic cells during fetal development cause idiopathic autism

An international research group led by Professor Toru Takumi (Senior Visiting Scientist, RIKEN Center for Biosystems Dynamics Research) and Researcher Chia-wen Lin at Kobe University Graduate School of Medicine has shown that idiopathic autism is caused by epigenetic abnormalities in hematopoietic cells during fetal development, which results in immune dysregulation in the brain and gut.

2 May 2022

Detailed estimates of cancer incidence, mortality and survival in Canada

Overall cancer rates in Canada are declining, but the number of cases and deaths are increasing slightly because of population growth and an aging population, according to a new study on cancer data published in CMAJ.

2 May 2022

Obesity progression may contribute to the economic burden of the disease, studies suggest

Obesity is known to approximately double healthcare costs in the US compared to those with a healthy weight.

2 May 2022

British children's sugar intake exceeds current public health recommendations

A new study, being presented at this year's European Congress on Obesity (ECO) in Maastricht, Netherlands (4-7 May), suggests that children in the UK start consuming free sugars (those added to foods and drinks and those occurring naturally in fruit juices, honey and syrups) at a very young age, and that many toddlers' sugar intake exceeds the maximum recommended amount for children aged 4 and older.

2 May 2022

SARS-CoV-2-specific T cells are broader after vaccination than after infection

In a recent study published in the Nature Microbiology journal, researchers investigated the characteristics of coronavirus disease 2019 (COVID-19) infection in convalescent and vaccinated individuals.

1 May 2022

Study finds 67% of individuals with long COVID are developing dysautonomia

In a recent study posted to the medRxiv* preprint server, researchers analyzed the traits of autonomic symptom burden in long coronavirus disease (COVID).

1 May 2022

How diet and nutrition impacts lifespan

In a recent study published in the journal Cell, researchers analyzed the association between human longevity to growth and metabolic pathways.

1 May 2022

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

In a recent study published in the Nature Microbiology journal, researchers assessed the longitudinal viral dynamics in asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

1 May 2022

$Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?$

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

A recent research paper posted to the Research Square* preprint server assessed the dose fractionation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.

1 May 2022

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

A recent research paper posted to the bioRxiv* preprint server demonstrated that a cocktail of two synergetic antibodies extensively neutralized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, including Omicron BA.1 and BA.2.

1 May 2022

New cardiac defibrillator implanted under the skin greatly reduces patient complications

High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications with a type of device implanted under the skin, a Canadian study has found.

30 Apr 2022

Researchers test a method for delivering genetic material into the body to repair damaged heart muscle

A method for delivering genetic material to the body is being tested as a way to repair damaged heart muscle after a heart attack.

30 Apr 2022

Trial shows the efficacy of anti-TNF drug for patients with early-stage Dupuytren's disease

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early-stage Dupuytren's disease.

30 Apr 2022

University of Arizona, Oklahoma State University join forces to combat opioid crisis and chronic pain

Robert C. Robbins, MD, president of the University of Arizona, and Kayse Shrum, DO, president of Oklahoma State University, today announced the two institutions’ academic medical centers have joined forces to combat the opioid crisis and chronic pain through research, treatment and education.

30 Apr 2022

Weill Cornell Medicine honors students, staff for exemplary efforts to promote diversity and inclusion

Weill Cornell Medicine honored a dozen faculty, trainees, students and staff April 25 for their outstanding service and leadership in promoting diversity at the academic medical institution.

29 Apr 2022

Roswell Park's nursing teams share research at 47th Annual Congress of the Oncology Nursing Society

Several nursing teams from Roswell Park Comprehensive Cancer Center were invited to share their research at the 47th Annual Congress of the Oncology Nursing Society, which is underway in Anaheim, California, and continues through May 1, 2022.

29 Apr 2022

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

A novel therapy developed at the University of Alabama at Birmingham ameliorates obesity and Type 2 diabetes in mice fed a high-fat diet.

29 Apr 2022

Scientists gain important insights into novel mutation behind synucleinopathies

Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called Lewy bodies and Lewy neurites in the brain.

29 Apr 2022

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

A new study describes the development of new molecules with inhibitory activity against the SARS-CoV-2 viral main protease (Mpro) enzyme, based on rattlesnake venom.

29 Apr 2022

Medical News

Higher vaccination coverage associated with lower rates of population-level COVID-19 mortality and incidence in the US

Epigenetic abnormalities in hematopoietic cells during fetal development cause idiopathic autism

Detailed estimates of cancer incidence, mortality and survival in Canada

Obesity progression may contribute to the economic burden of the disease, studies suggest

British children's sugar intake exceeds current public health recommendations

SARS-CoV-2-specific T cells are broader after vaccination than after infection

Study finds 67% of individuals with long COVID are developing dysautonomia

How diet and nutrition impacts lifespan

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

Can fractional doses of COVID-19 vaccines protect against SARS-CoV-2?

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

New cardiac defibrillator implanted under the skin greatly reduces patient complications

Researchers test a method for delivering genetic material into the body to repair damaged heart muscle

Trial shows the efficacy of anti-TNF drug for patients with early-stage Dupuytren's disease

University of Arizona, Oklahoma State University join forces to combat opioid crisis and chronic pain

Weill Cornell Medicine honors students, staff for exemplary efforts to promote diversity and inclusion

Roswell Park's nursing teams share research at 47th Annual Congress of the Oncology Nursing Society

Novel therapy using nitric oxide may be an efficient and safe way to treat multiple metabolic diseases

Scientists gain important insights into novel mutation behind synucleinopathies

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News